Cardiac Imaging
L1 subspecialty spine topic for Cardiac Imaging (seeded from backend/data/cardiology_taxonomy.yaml).
Also called echo, CMR, CT-FFR, strain imaging
Sources: 12 new papers · 5 key papers · updated Oct 20, 2026
Unverified · drafted by AI from the sources cited below
Myocardial strain imaging by echocardiography or cardiac magnetic resonance is a method used to diagnose cardiac disease by providing measures of myocardial shortening, thickening, and lengthening.1
Left ventricular global longitudinal strain is a more sensitive method than ejection fraction for diagnosing mild systolic dysfunction.1 In coronary artery disease, a functional SYNTAX score based on CT-FFR can predict major adverse cardiovascular events and reclassify patient risk.2 For instance, in a cohort of 876 patients, 10.4% and 2.9% of patients were reclassified to low-risk and intermediate-to-high-risk groups, respectively, using a threshold of 22.2 CT-FFR with a cutoff of 0.80 can identify angiographic in-stent restenosis3 and diagnose cerebral hypoperfusion in patients with 30 - 99% intracranial atherosclerotic stenosis.4 Furthermore, an artificial intelligence-based, fully-automated CT-FFR model demonstrated a diagnostic accuracy of 0.82 on a per-patient level in a cohort of 463 patients with 600 vessels.5 Radiomics of pericoronary adipose tissue also offer incremental diagnostic value over anatomical and physiological assessment, as demonstrated in a study of 81 patients and 107 target vessels evaluated within 30 days.6
On-site CT-FFR pathways are utilized to guide management in patients with stable coronary artery disease who have an intermediate stenosis of 30% to 90%.1 In an evaluation of 973 symptomatic patients, planned revascularization within 90 days occurred in 39.8% of those with a CT-FFR of 0.71 to 0.75, compared to 19.3% in those with a CT-FFR of 0.76 to 0.80.2
Many deep learning models in cardiac imaging are considered a black box, highlighting a need to transition to explainable artificial intelligence methods to ensure outcomes are transparent.1 While physiological assessment via CT-FFR is widely used, adverse events can still occur without functionally significant ischemia, leading to ongoing evaluations of whether biomarkers like circulating trimethylamine N-oxide provide complementary prognostic value.2
Impact of cardiac phase selection on the diagnostic performance of CT-FFR: the role of myocardial bridging and heart rate
BMC Medical Imaging — Song J — Nov 2026
The Predictive Value of AI-Based FAI Combined with CT-FFR for Prognosis in Hyperuricemia Patients with Coronary Artery Stenosis
Li J — Nov 2026
15 O‐water PET‐detected myocardial ischaemia and CT‐derived FFR: Predicting the functional significance of anatomical stenosis
Clinical Physiology and Functional Imaging — J V — Oct 2026
Prognostic association of non-alcoholic fatty liver disease and CT-derived fractional flow reserve in suspected coronary artery disease
BMC Cardiovascular Disorders — Li S — Oct 2026
Ramus Intermedius Anatomy and Left Main Coronary Geometry on Coronary Computed Tomography Angiography: A Retrospective Single-Center Study
Lv H — Oct 2026
Residual Cardiovascular Risk Beyond Coronary Physiology: Complementary Prognostic Value of Trimethylamine N‐Oxide in Patients Undergoing Coronary Computed Tomography Angiography With Computed Tomography‐Derived Fractional Flow Reserve
Journal of the American Heart Association — Shao B — Oct 2026
EXPRESS: Diagnostic and prognostic value of on-site CT-derived fractional flow reserve in intracranial atherosclerotic stenosis
Journal of Cerebral Blood Flow & Metabolism — Wang X — Oct 2026
Prognostic Implication of a CT-FFR-Based Functional SYNTAX Score in Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention
Journal of Clinical Medicine — Shao Q — Oct 2026
Machine learning CT-FFR for physiologic decision-making in diffuse coronary artery disease
European Heart Journal — An Z — Oct 2026
Predictive value of CT-FFR in right anomalous aortic origin of coronary artery in an adult population
European Heart Journal — Bigler M — Oct 2026
Myocardial Strain Imaging
JACC. Cardiovascular imaging — Smiseth O
251 citations · 2024 · among the most cited on Cardiac Imaging
Explainable Artificial Intelligence and Cardiac Imaging: Toward More Interpretable Models
Circulation Cardiovascular Imaging — Salih A
134 citations · 2023 · among the most cited on Cardiac Imaging
On-Site Computed Tomography–Derived Fractional Flow Reserve to Guide Management of Patients With Stable Coronary Artery Disease: The TARGET Randomized Trial
Circulation — Yang J
111 citations · 2023 · among the most cited on Cardiac Imaging
Diagnostic and prognostic performance of artificial intelligence-based fully-automated on-site CT-FFR in patients with CAD
Science Bulletin — Guo B
89 citations · 2024 · among the most cited on Cardiac Imaging
Reflections on project ECHO: qualitative findings from five different ECHO programs
Medical Education Online — Agley J
69 citations · 2021 · among the most cited on Cardiac Imaging
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.